Our previous application set up the hypothesis that certain forms of periodontitis were specific infections due to proportional overgrowth of anaerobic species, such as spirochetes and B. gingivalis. We have conducted double blind studies using metronidazole, which showed that patients who received tooth surface debridement and one week of systemic metronidazole required significantly less periodontal surgery than the control patients. In the current proposal we seek to determine whether periodontal surgery can be reduced and/or eliminated by root surface debridement plus the usage of drugs directed against periodontopathic organisms and/or the host's inflammatory response. The drugs to be evaluated will be metronidazole and tetracycline, each taken systemically for a two-week period after the scaling and root planing is completed. Teeth that are refractory to this regimen and still require some form of periodontal surgery will have ethylcellulose films containing either metronidazole or chlorhexidine placed within their pockets for one week or more. These films are fabricated so that the drug is slowly released over a 3- to 10-day period. The reduction in surgical needs will be judged by clinical criteria and will be verified by standardize radiographs and bacteriological parameters. Patients seen at the annual recall visit will receive either metronidazole or tetracycline in a double blind design to determine the prophylactic value of periodic antimicrobial treatment during the maintenance phase. Bacteriological parameters will be obtained throughout the study period. In a related investigation, patients who have an anaerobic periodontal infection will receive metronidazole or placebo under supervision. The serum and saliva levels of metronidazole will be compared with the changes in levels and proportions of spirochetes in the plaque and with the ability of the plaque to hydrolyze the trypsin substrate BANA. In this way we hope to determine whether patient compliance in the systemic usage of metronidazole can be measured by changes in the plaque levels and/or proportions of spirochetes or in the ability of the plaque to hydrolyze BANA. Finally, we will develop and deploy slow release ethylcellulose film systems for the delivery of nonsteroidal anti-inflammatory agents, such as indomethacin to the periodontal pocket either alone or in combination with metronidazole or chlorhexidine.
| Loesche, Walter J; Giordano, James R; Soehren, Stephen et al. (2005) The nonsurgical treatment of patients with periodontal disease: results after 6.4 years. Gen Dent 53:298-306; quiz 307 |
| Loesche, Walter J; Giordano, James R; Soehren, Stephen et al. (2002) The nonsurgical treatment of patients with periodontal disease: results after five years. J Am Dent Assoc 133:311-20 |
| Loesche, W J; Grossman, N S (2001) Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 14:727-52, table of contents |
| Loesche, W J (1999) The antimicrobial treatment of periodontal disease: changing the treatment paradigm. Crit Rev Oral Biol Med 10:245-75 |
| Loesche, W J; Giordano, J R (1997) Treatment paradigms in periodontal disease. Compend Contin Educ Dent 18:221-6, 228-30, 232 passim; quiz |
| Loesche, W J; Taylor, G; Giordano, J et al. (1997) A logistic regression model for the decision to perform access surgery. J Clin Periodontol 24:171-9 |
| Loesche, W J; Giordano, J; Soehren, S et al. (1996) Nonsurgical treatment of patients with periodontal disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:533-43 |
| De Boever, E H; De Uzeda, M; Loesche, W J (1994) Relationship between volatile sulfur compounds, BANA-hydrolyzing bacteria and gingival health in patients with and without complaints of oral malodor. J Clin Dent 4:114-9 |
| Loesche, W J; Giordano, J R (1994) Metronidazole in periodontitis V: debridement should precede medication. Compendium 15:1198, 1201, 1203 passim;quiz 12 |
| Loesche, W J; Grossman, N; Giordano, J (1993) Metronidazole in periodontitis (IV). The effect of patient compliance on treatment parameters. J Clin Periodontol 20:96-104 |
Showing the most recent 10 out of 23 publications
